Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
Antiepileptic drugs: indications other than epilepsy
2004
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Analysis of macrolide antibiotics
1998
Brown and beige fat: development, function and therapeutic potential
2013 Standout
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Clinical approaches to treatment of Internet addiction
2014 Standout
Mood Disorders in Patients with Epilepsy
2002
Interventions to achieve long-term weight loss in obese older people: A systematic review and meta-analysis
2010
Therapeutic Safety Monitoring: What to Look for and When to Look for It
2000
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
2000
Medication Compliance and Persistence: Terminology and Definitions
2007 Standout
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Weight Reduction and Cardiovascular and Metabolic Disease Prevention: Clinical Trial Update
2007
Rise and fall of anti-obesity drugs
2011
Effects of Antiepileptic Drugs on Sleep Structure
2003
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms
2007
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Botulinum Toxin Type A (BOTOX ® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2005
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
2008
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
2008
Overview of pediatric headache
2004
The different shades of fat
2014 Nature
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
2012
Cardiovascular effects of phentermine and topiramate
2014
Chronic cold exposure results in subcutaneous adipose tissue browning and altered global metabolism in Qinghai-Tibetan plateau pika (Ochotona curzoniae)
2018 StandoutNobel
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group
2004 Standout
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
2005
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
2001
EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
2009
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
2010
What We Talk About When We Talk About Fat
2014 Standout
BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
2012
Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Exploratory Study
2006
QT Prolongation and Torsades de Pointes Associated with Clarithromycin
1998
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
2012 Standout
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
2014
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Protective autoimmunity: interferon‐γ enables microglia to remove glutamate without evoking inflammatory mediators
2005
The evolution and role of macrolides in infectious diseases
2002
Drug Treatment for Obesity in the Post-Sibutramine Era
2011
Chronic Daily Headache
2006
European Guidelines for Obesity Management in Adults
2015 Standout
Results of a naturalistic study of treatment options: Switching atypical antipsychotic drugs or augmenting with valproate
2004
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
A Neurologist’s Guide to Acute Migraine Therapy in the Emergency Room
2012
Hazard analysis: A deep learning and text mining framework for accident prevention
2020 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
2010 Standout
The macrolides
2002
Non-epilepsy uses of antiepilepsy drugs.
2006
The Importance of Placebo in Headache Research
2008
Measuring the whole or the parts?
2001 Standout
Ribosomal Crystallography: Peptide Bond Formation, Chaperone Assistance and Antibiotics Activity
2005 StandoutNobel
Users' Guides to the Medical Literature
1997
A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Multiple Treatments of Botulinum Toxin Type A (BoNTA) for the Prophylaxis of Episodic Migraine Headaches
2007
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Review of the key results from the Swedish Obese Subjects (SOS ) trial – a prospective controlled intervention study of bariatric surgery
2013 Standout
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults
2012
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Safety of antiobesity drugs
2013
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Guideline for primary care management of headache in adults.
2015 Standout
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout
Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial
1998
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Roger Deaton being referenced
Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin
2000
Safety of tiagabine: summary of 53 trials
1999
Single‐ and Multiple‐dose Pharmacokinetics of Clarithromycin, a New Macrolide Antimicrobial
1993
A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis
2002
Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood
2000
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial
2007
Migraine Prophylaxis With Divalproex
1995
Absolute bioavailability of clarithromycin after oral administration in humans
1992